
Andrew Kline
Professional Bio
Andrew Kline leverages his more than thirty years of law and policy experience in his diverse practice. He counsels clients in established and emerging industries on regulatory compliance, due diligence, internal investigations, privacy, public policy, and litigation strategy.
FDA Issues New Warning Letters For Delta-8 and CBD Products
Cannabis Legal Highlights ·
Dr. Robert Califf Confirmed to Head FDA
Cannabis Legal Highlights ·
Introduction of Senate Cannabis Descheduling Bill Anticipated in April 2022
Cannabis Legal Highlights ·
FDA Releases Plan to Obtain Data Regarding Cannabis-Derived Product Usage & Safety
Cannabis Legal Highlights ·
The Role of State AGs in Cannabis Policy and Regulation: A Conversation with Austin Bernstein
Cannabis Legal Highlights ·